SPRY: ARS Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SPRY: ARS Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,314.81
Enterprise Value ($M) 1,333.37
Book Value ($M) 256.80
Book Value / Share 2.62
Price / Book 5.12
NCAV ($M) 239.94
NCAV / Share 2.45
Price / NCAV 5.48

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 14.04
Current Ratio 14.26

Balance Sheet (mrq) ($M)
Current Assets 334.30
Assets 351.15
Liabilities 94.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 89.15
Operating Income -3.08
Net Income 8.00

Cash Flow Statement (mra) ($M)
Cash From Operations 13.55
Cash from Investing -106.10
Cash from Financing 72.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-24 13D/A Deerfield Mgmt III, L.P. 10.72
06-17 13D/A Pratik Shah Living Trust dated June 15, 2011 5.40 -20.34
2024-03-29 13D/A Ra Capital Management, L.p. 11.30 14.81

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-12-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 685,989 2,398,946 28.60
2025-04-03 1,079,364 2,399,883 44.98
2025-04-02 492,833 1,369,844 35.98
2025-04-01 411,267 1,322,067 31.11
2025-03-31 422,584 1,452,550 29.09

(click for more detail)

Similar Companies
SIGA – SIGA Technologies, Inc. SKYE – Skye Bioscience, Inc.
SMMT – Summit Therapeutics Inc. STRO – Sutro Biopharma, Inc.
SUPN – Supernus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io